Every year there are approximately 2200 to 3000 cases of invasive meningococcal disease in the United States. Because of its low cost effectiveness and other limitations, routine use of the meningococcal vaccine is not recommended. However, individual choices may differ from public policy considerations. If parents were aware of this option, many might choose to pay for vaccination in order to protect adolescents and young adults from this devastating infection. Parents and patients need information about the availability of all effective vaccines.
No takes yet. Share an insight, caveat, or question.
Offit et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: